Leukemia & lymphoma · 2026
Clinicopathologic spectrum and outcomes of primary ovarian lymphoma: a retrospective case series.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Shan Ying, Chen Xiaoling, Li Dahui, Zhang Wenhao, Chen Dong, Xin Yuting, Liu Chuanxu, Li Shuangyue, Wang Tiantian, Shi Xiaowei, Ye Peipei, Zhou Fan, Lu Ying, Tao Rong
Аннотация
Primary ovarian lymphoma (POL) is rare and often presents as an adnexal mass, creating diagnostic and management challenges. We performed a retrospective cohort study of 13 women diagnosed with POL between January 2018 and December 2023. Median age was 44 years (range 13-69), with 69.2% being premenopausal. LDH was elevated in 9/13 (69.2%) and CA-125 in 8/10 (80.0%) while CEA and CA19-9 were negative. Histology was heterogeneous: diffuse large B-cell lymphoma (DLBCL, 46.2%), extranodal NK/T-cell lymphoma (23.1%), Burkitt lymphoma (15.4%), marginal zone lymphoma (7.7%), and follicular lymphoma (7.7%). Median follow-up was 28 months (range 0.5-84). Three deaths occurred, all in patients without timely systemic therapy. Estimated 5-year OS was approximately 76.9% (95% CI, 57.1%-100%). In this contemporary POL series, clinicopathologic heterogeneity was prominent, and laboratory profiles frequently overlapped with ovarian malignancy work-up. Outcomes may be favorable among patients receiving timely, subtype-appropriate systemic treatment.